SAB Biotherapeutics Inc. (SABS) NASDAQ
$4.46 - (-)
Market Cap: $41.15M
As of 04/18/24 12:00 AM EDT. Market closed.
SAB Biotherapeutics Inc. (SABS)
NASDAQ
$4.46
- (-)
Market Cap: $41.15M
As of 04/18/24 12:00 AM EDT. Market closed.
Add to Portfolio
sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving ... read more
sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
81
Address
.
PRICE CHART FOR SAB BIOTHERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$4.46
Days Range
$4.34 - $4.41
52 week range
$4 - $11.90
Volume
891
Avg. Volume (30 days)
4,831
Market Cap
$41.15M
Dividend Yield
-
P/E
(0.98)
Shares Outstanding
9,225,494
Open
-
Previous Close
$4.46
Days Range
$4.34 - $4.41
52 week range
$4 - $11.90
Volume
891
Avg. Volume (30 days)
4,831
Market Cap
$41.15M
Dividend Yield
-
P/E
(0.98)
Shares Outstanding
9,225,494
FINANCIAL STATEMENTS FOR SAB BIOTHERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SAB BIOTHERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Sullivan Eddie Joe | Chief Executive Officer | Dec 07, 2023 | Buy | $0.88 | 1,740 | 1,531 | 5,232,304 | Dec 08, 2023, 08:00 AM |
| King Michael | CHIEF FINANCIAL OFFICER | Nov 30, 2023 | Buy | $0.90 | 5,000 | 4,500 | 5,000 | Nov 30, 2023, 05:00 PM |
| Reich Samuel J | Executive Chairman | Nov 29, 2023 | Buy | $0.89 | 11,000 | 9,842 | 219,001 | Nov 30, 2023, 08:00 AM |
| HAMILTON CHRISTINE E | Director | Dec 07, 2022 | Option Exercise | $1.21 | 82,987 | 99,999 | 3,111,334 | Dec 09, 2022, 04:31 PM |
| Spragens Jeffrey G | Director | Dec 07, 2022 | Option Exercise | $1.21 | 82,987 | 99,999 | 394,989 | Dec 09, 2022, 09:02 AM |
| Link David Charles | Director | Dec 07, 2022 | Option Exercise | $1.21 | 41,493 | 49,999 | 57,313 | Dec 09, 2022, 09:01 AM |
| HAMILTON CHRISTINE E | Director | Sep 13, 2022 | Buy | $0.73 | 10,000 | 7,297 | 4,993,090 | Sep 14, 2022, 05:16 PM |
| Sullivan Eddie Joe | CHIEF EXECUTIVE OFFICER | Sep 07, 2022 | Buy | $0.74 | 14,000 | 10,315 | 5,230,564 | Sep 08, 2022, 04:31 PM |
| Beyer Russell P | Chief Financial Officer | Sep 29, 2021 | Option Exercise | $10.08 | 10 | 101 | 15 | Nov 16, 2021, 03:09 PM |
| Beyer Russell P | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $10.07 | 5 | 50 | 5 | Nov 16, 2021, 03:09 PM |
| Beyer Russell P | Chief Financial Officer | Oct 25, 2021 | Option Exercise | $7.78 | 129 | 1,004 | 278 | Nov 16, 2021, 03:09 PM |
| Beyer Russell P | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $10.08 | 149 | 1,502 | 149 | Nov 16, 2021, 03:09 PM |
| Beyer Russell P | Chief Financial Officer | Oct 18, 2021 | Option Exercise | $10.10 | 2,475 | 24,998 | 2,475 | Nov 16, 2021, 03:09 PM |
| Beyer Russell P | Chief Financial Officer | Oct 26, 2021 | Sale | $7.90 | 278 | 2,196 | 0 | Nov 16, 2021, 03:09 PM |
| Hamilton Edward D. | 10% Owner | Oct 12, 2021 | Option Exercise | $10.09 | 50,000 | 504,250 | 25,000 | Oct 26, 2021, 09:51 PM |
| Hamilton Edward D. | 10% Owner | Oct 14, 2021 | Option Exercise | $10.10 | 5,092 | 51,429 | 5,092 | Oct 26, 2021, 09:51 PM |
| Hamilton Edward D. | 10% Owner | Oct 13, 2021 | Option Exercise | $10.10 | 20,800 | 210,080 | 20,800 | Oct 26, 2021, 09:51 PM |
| Hamilton Edward D. | 10% Owner | Oct 01, 2021 | Option Exercise | $10.10 | 2,695 | 27,220 | 2,695 | Oct 26, 2021, 09:51 PM |
| Luke Thomas Charles | Chief Medical Officer | Oct 19, 2021 | Option Exercise | $10.10 | 990 | 9,999 | 990 | Oct 26, 2021, 09:50 PM |
| Sullivan Eddie Joe | Chief Executive Officer | Oct 07, 2021 | Option Exercise | $10.07 | 2,800 | 28,196 | 2,800 | Oct 26, 2021, 09:50 PM |
| HAMILTON CHRISTINE E | Director | Oct 14, 2021 | Option Exercise | $10.10 | 5,092 | 51,429 | 5,092 | Oct 26, 2021, 09:48 PM |
| HAMILTON CHRISTINE E | Director | Oct 13, 2021 | Option Exercise | $10.10 | 20,800 | 210,080 | 20,800 | Oct 26, 2021, 09:48 PM |
| HAMILTON CHRISTINE E | Director | Oct 01, 2021 | Option Exercise | $10.10 | 2,695 | 27,220 | 2,695 | Oct 26, 2021, 09:48 PM |
| HAMILTON CHRISTINE E | Director | Oct 12, 2021 | Option Exercise | $10.08 | 25,000 | 252,000 | 25,000 | Oct 26, 2021, 09:48 PM |
| HAMILTON CHRISTINE E | Director | Oct 12, 2021 | Option Exercise | $10.09 | 25,000 | 252,250 | 25,000 | Oct 26, 2021, 09:48 PM |
| Katz Ilan | Director | Oct 13, 2021 | Buy | $10.10 | 500 | 5,052 | 1,500 | Oct 15, 2021, 10:51 AM |
| Reich Samuel J | CEO and CFO | Oct 14, 2021 | Buy | $10.11 | 1,000 | 10,110 | 1,000 | Oct 15, 2021, 10:48 AM |
| Spragens Jeffrey G | Director | Oct 01, 2021 | Buy | $10.07 | 13,000 | 130,910 | 13,000 | Oct 05, 2021, 05:00 PM |
| Katz Ilan | Director | Oct 01, 2021 | Buy | $10.09 | 1,000 | 10,090 | 1,000 | Oct 05, 2021, 05:00 PM |
| Reich Samuel J | CEO and CFO | Jan 14, 2021 | Buy | $10.00 | 417,200 | 4,172,000 | 3,047,825 | Jan 14, 2021, 01:33 PM |
| Katz Ilan | Director | Jan 14, 2021 | Buy | $10.00 | 417,200 | 4,172,000 | 3,047,825 | Jan 14, 2021, 01:32 PM |
| Big Cypress Holdings LLC | CEO and CFO | Jan 14, 2021 | Buy | $10.00 | 417,200 | 4,172,000 | 3,047,825 | Jan 14, 2021, 01:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Sullivan Eddie Joe | Chief Executive Officer | 12/07/2023 | 1,531 |
| King Michael | CHIEF FINANCIAL OFFICER | 11/30/2023 | 4,500 |
| Reich Samuel J | Executive Chairman | 11/29/2023 | 9,842 |
| HAMILTON CHRISTINE E | Director | 12/07/2022 | 99,999 |
| Spragens Jeffrey G | Director | 12/07/2022 | 99,999 |
| Link David Charles | Director | 12/07/2022 | 49,999 |
| HAMILTON CHRISTINE E | Director | 09/13/2022 | 7,297 |
| Sullivan Eddie Joe | CHIEF EXECUTIVE OFFICER | 09/07/2022 | 10,315 |
| Beyer Russell P | Chief Financial Officer | 09/29/2021 | 101 |
| Beyer Russell P | Chief Financial Officer | 09/28/2021 | 50 |
| Beyer Russell P | Chief Financial Officer | 10/25/2021 | 1,004 |
| Beyer Russell P | Chief Financial Officer | 09/28/2021 | 1,502 |
| Beyer Russell P | Chief Financial Officer | 10/18/2021 | 24,998 |
| Beyer Russell P | Chief Financial Officer | 10/26/2021 | 2,196 |
| Hamilton Edward D. | 10% Owner | 10/12/2021 | 504,250 |
| Hamilton Edward D. | 10% Owner | 10/14/2021 | 51,429 |
| Hamilton Edward D. | 10% Owner | 10/13/2021 | 210,080 |
| Hamilton Edward D. | 10% Owner | 10/01/2021 | 27,220 |
| Luke Thomas Charles | Chief Medical Officer | 10/19/2021 | 9,999 |
| Sullivan Eddie Joe | Chief Executive Officer | 10/07/2021 | 28,196 |
| HAMILTON CHRISTINE E | Director | 10/14/2021 | 51,429 |
| HAMILTON CHRISTINE E | Director | 10/13/2021 | 210,080 |
| HAMILTON CHRISTINE E | Director | 10/01/2021 | 27,220 |
| HAMILTON CHRISTINE E | Director | 10/12/2021 | 252,000 |
| HAMILTON CHRISTINE E | Director | 10/12/2021 | 252,250 |
| Katz Ilan | Director | 10/13/2021 | 5,052 |
| Reich Samuel J | CEO and CFO | 10/14/2021 | 10,110 |
| Spragens Jeffrey G | Director | 10/01/2021 | 130,910 |
| Katz Ilan | Director | 10/01/2021 | 10,090 |
| Reich Samuel J | CEO and CFO | 01/14/2021 | 4,172,000 |
| Katz Ilan | Director | 01/14/2021 | 4,172,000 |
| Big Cypress Holdings LLC | CEO and CFO | 01/14/2021 | 4,172,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SAB BIOTHERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 2,374,081 | 0.03% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 356,364 | 0.00003% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 63,100 | 0.00007% | 8.61% | Other |
| BLACKROCK INC. | 52,643 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR SAB BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR SAB BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
-87.17%
5Q
06/30/2022
-87.16%
6Q
03/31/2022
-87.95%
7Q
12/31/2021
-82.44%
8Q
09/30/2021
-78.74%
9Q
06/30/2021
-78.74%
10Q
03/31/2021
-80.33%
11Q
12/31/2020
-79.56%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SAB BIOTHERAPEUTICS INC
LOADING...